Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group.

Saved in:
Bibliographic Details
Title: Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative Group.
Authors: Otiato, Maxwell1 (AUTHOR), Moghaddam, Farshad Sheybaee1,2 (AUTHOR), Ghoreifi, Alireza1,3 (AUTHOR), Autorino, Riccardo2,4 (AUTHOR), Bignante, Gabriele2,5 (AUTHOR), Sundaram, Chandru3,6 (AUTHOR), Sidhom, Daniel3,7 (AUTHOR), Derweesh, Ithaar H.4,8 (AUTHOR), Puri, Dhruv4,9 (AUTHOR), Margulis, Vitaly5,10 (AUTHOR), Popokh, Benjamin5,11 (AUTHOR), Abdollah, Firas6,12 (AUTHOR), Stephens, Alex6,13 (AUTHOR), Ferro, Matteo7,14 (AUTHOR), Simone, Giuseppe8,15 (AUTHOR), Tuderti, Gabriele8,16 (AUTHOR), Mehrazin, Reza9,17 (AUTHOR), Eraky, Ahmed9,18 (AUTHOR), Gonzalgo, Mark10,19 (AUTHOR), Nativ, Omar Falik10,20 (AUTHOR)
Source: Cancers. Jul2025, Vol. 17 Issue 13, p2144. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers17132144